Scholarly Index
Solomon J. Lubinga
GlaxoSmithKline (United States); 705 total citations; 59 total publications; best world rank #552
GlaxoSmithKline (United States)
705Total citations
59Total publications
15H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Economic and Financial Impacts of Cancer | 2021-2025 | 552 | US 341 | 87.48 |